alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 2,826–2,850 of 7,816 matching trials · page 114 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Preventing Medication Mismanagement in People Living with Dementia Through Automated Medication Dispensing with Facial Recognition and Video Observation
NCT06691256
HiDO-ALZ
Runs in: United States · 1 site 		PHASE2
other		 ACTIVE_NOT_RECRUITING 70 HiDO Technologies
INDUSTRY		 2025-01-30
Effectiveness of Attention/executivefunctions Training on Prospective Memory Abilities of Parkinson's Disease Subjects with Mild Cognitive Impairment and Healthy Aged Individuals: a Placebo-controlled Study with a Combined Immersive Virtual Reality and Telemedicine Approach
NCT06801782
Experimental Cognitive training in Immersive Virtual Reality and Te...
Runs in: Italy · 1 site 		NA
other		 COMPLETED 60 I.R.C.C.S. Fondazione Santa Lucia
OTHER		 2025-01-30
Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
NCT05161715
Obicetrapib
Runs in: Netherlands · 1 site 		PHASE2
other		 COMPLETED 13 NewAmsterdam Pharma
INDUSTRY		 2025-01-29
Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS
NCT05852405
Runs in: Germany · 1 site 		NA
other		 COMPLETED 2,000 Ambulanzpartner Soziotechnologie APST GmbH
INDUSTRY		 2025-01-29
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
NCT06069843
IV Ketamine
Runs in: United States · 1 site 		PHASE2
other		 ACTIVE_NOT_RECRUITING 15 Icahn School of Medicine at Mount Sinai
OTHER		 2025-01-29
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
NCT06284213
No interventions
Runs in: United States · 17 sites 		NA
other		 ACTIVE_NOT_RECRUITING 1,892 Massachusetts General Hospital
OTHER		 2025-01-29
tDCS Intervention in Primary Progressive Aphasia
NCT02606422
Active HD-tDCS plus Speech-Language Therapy; Sham plus Speech-Langu...
Runs in: United States · 1 site 		NA
other		 COMPLETED 61 Johns Hopkins University
OTHER		 2025-01-28
Hormone Replacement Trial Against ALzheimers' Disease
NCT04312399
blood take
Runs in: Belgium · 1 site 		NA
other		 RECRUITING 600 University Hospital, Ghent
OTHER		 2025-01-27
Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study
NCT06391853
Insulin; Placebo 		NA
other		 WITHDRAWN 0 Erasme University Hospital
OTHER		 2025-01-27
Mindfulness for Cognition in Early-stage Alzheimer's Disease
NCT06792877
Mindfulness Intervention; Waitlist then mindfulness
Runs in: United States · 1 site 		NA
other		 RECRUITING 100 VA Boston Healthcare System
OTHER_GOV		 2025-01-27
Virtual Reality in Cognitive Stimulation Therapy for Visually Impaired Older Individuals with Dementia
NCT06793384
Virtual reality based Cognitive Stimulation Therapy (VR-CST); Conve...
Runs in: Hong Kong · 1 site 		NA
other		 COMPLETED 31 The Hong Kong Polytechnic University
OTHER		 2025-01-27
Effect of Food and Age on the Pharmacokinetics of LY03017
NCT06793995
LY03017; LY03017
Runs in: China · 1 site 		PHASE1
other		 NOT_YET_RECRUITING 26 Luye Pharma Group Ltd.
INDUSTRY		 2025-01-27
Paired Integrative Exercise Program for People With Dementia and Caregivers
NCT02729311
Paired PLIÉ Program; Waitlist control
Runs in: United States · 1 site 		NA
other		 COMPLETED 60 University of California, San Francisco
OTHER		 2025-01-24
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
NCT05058040
Sodium Oligomannate Capsules
Runs in: China · 63 sites 		PHASE4
other		 ACTIVE_NOT_RECRUITING 2,500 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
INDUSTRY		 2025-01-24
EXploring Patterns of Use and Effects of Adult Day Programs to Improve Trajectories of Continuing CarE
NCT06440447
Adult day program use; Other community care (non-attendees) 		NA
other		 NOT_YET_RECRUITING 500,000 York University
OTHER		 2025-01-24
Assessing the Impact of DAy Programs on Individuals Living with Dementia and Their Family/friend Caregivers
NCT06496945
Adult day program use; Other community care (non-attendees)
Runs in: Canada · 4 sites 		NA
other		 RECRUITING 3,000 York University
OTHER		 2025-01-24
Chronic Insomnia and CSF Markers of Dementia
NCT04024020
lumbar puncture
Runs in: United States · 1 site 		NA
other		 COMPLETED 30 University of Pennsylvania
OTHER		 2025-01-23
A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers
NCT04983368
Xanamem® 5 mg; Placebo; Xanamem® 10 mg
Runs in: Australia · 5 sites 		PHASE1|PHASE2
other		 COMPLETED 107 Actinogen Medical
INDUSTRY		 2025-01-23
A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
NCT05104463
CST-2032, matching placebo for CST-2032, CST-107, matching placebo ...
Runs in: New Zealand; United States · 15 sites 		PHASE2
other		 COMPLETED 64 CuraSen Therapeutics, Inc.
INDUSTRY		 2025-01-23
Dynamic Response to Probiotics in Context of Alzheimer Disease: a Proof-of-concept Study
NCT05521477
SLAB51
Runs in: Switzerland · 1 site 		NA
other		 COMPLETED 3 University Hospital, Geneva
OTHER		 2025-01-23
Validating the Ain Shams Cognitive Assessment Tool
NCT06789094
Ain Shams University Cognitive Assessment (ASCA) tool
Runs in: Egypt · 1 site 		NA
other		 NOT_YET_RECRUITING 100 Ain Shams University
OTHER		 2025-01-23
A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease
NCT06702124
Rotigotine 4Mg/24Hrs Patch; Placebo
Runs in: Italy · 1 site 		PHASE3
symptomatic-cholinergic		 RECRUITING 348 I.R.C.C.S. Fondazione Santa Lucia
OTHER		 2025-01-22
Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study
NCT06626308
brain functional MRI
Runs in: France · 1 site 		NA
other		 RECRUITING 20 University Hospital, Grenoble
OTHER		 2025-01-20
Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease
NCT05423522
NanoLithium® NP03; Placebo
Runs in: France · 8 sites 		PHASE2
other		 COMPLETED 72 Medesis Pharma SA
INDUSTRY		 2025-01-17
Physical Activity and Disability Prevention in Postmenopausal Women
NCT06781541
Nordic walking; Strength training; Bungy Pump Exercises; Daily life...
Runs in: Poland · 1 site 		NA
other		 ACTIVE_NOT_RECRUITING 72 Gdansk University of Physical Education and Sport
OTHER		 2025-01-17

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →